Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

transcreation

Amiculum and Bionow logos

Amiculum joins Bionow: supporting collaboration across the life sciences sector in the North of the UK

We’re delighted that Amiculum has become a member of Bionow, joining a collaborative community that plays an important role in bringing together life sciences organizations across the North of the...

Amiculum

- PMLiVE

Angelini Pharma to acquire Catalyst Pharmaceuticals for $4.1bn

Catalyst Pharmaceuticals is focused on novel medicines for rare diseases

- PMLiVE

Legend Biotech appoints new group of scientific advisors

The company is focused on CAR-T cell therapy to treat multiple myeloma

- PMLiVE

Lilly commits additional $4.5bn for US manufacturing sites

The company has also opened its first dedicated genetic medicine facility in Indiana in the US

- PMLiVE

Langland appoints Victoria Kent as Managing Partner, Medical Strategy & Education

Most recently, Kent was Head of Syneos’ London Agency and its UK MedComms Lead

- PMLiVE

Havas Lynx celebrates 40 years of impact

Starting out in 1986 as a team of two in Manchester’s Northern Quarter, Havas Lynx has much to celebrate, having grown to become an international healthcare communications agency with offices...

Havas Lynx

New starters May 2026

Cuttsy+Cuttsy welcomes three new experts to the team

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

Cuttsy + Cuttsy

- PMLiVE

Durbin PLC becomes Uniphar, bolstering medicine access amidst growing healthcare demands

Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address industry-wide challenges, expanding its sourcing...

Uniphar

- PMLiVE

FDA gives Rare Paediatric Disease designation to Satellite Bio for urea cycle disorders

The mortality rates of UCDs exceeds 25%, with no curative treatment available for newborns

- PMLiVE

GC Therapeutics appoints Stefan Irion as Chief Scientific Officer

Irion was previously CSO at BlueRock Therapeutics, a Bayer subsidiary

- PMLiVE

Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access

Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence

Inizio

- PMLiVE

Personalization, automation and actionable intelligence: How to achieve purposeful innovation in healthcare communications

By Aaron Fletcher

Amiculum

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links